

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.63545404 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.63545404 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.80169325 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.80169325 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.53772972 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.53772972 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.53772972 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.53772972 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.53772972 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.53772972 |
| 11 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.27256825 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20618065 |
| 13 | positive regulation of nuclease activity (GO:0032075) | 4.18513210 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.03671471 |
| 15 | positive regulation of histone deacetylation (GO:0031065) | 3.93759198 |
| 16 | negative regulation of cell size (GO:0045792) | 3.91444742 |
| 17 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.84517909 |
| 18 | maternal placenta development (GO:0001893) | 3.82283286 |
| 19 | regulation of nuclease activity (GO:0032069) | 3.81884698 |
| 20 | protein retention in ER lumen (GO:0006621) | 3.78836430 |
| 21 | pentose-phosphate shunt (GO:0006098) | 3.66670381 |
| 22 | detection of bacterium (GO:0016045) | 3.65855228 |
| 23 | negative regulation of interleukin-6 production (GO:0032715) | 3.61782058 |
| 24 | detection of other organism (GO:0098543) | 3.57082659 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.54572356 |
| 26 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.53200174 |
| 27 | regulation of translational fidelity (GO:0006450) | 3.50755245 |
| 28 | response to peptidoglycan (GO:0032494) | 3.49831384 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.48748648 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.47014668 |
| 31 | regulation of early endosome to late endosome transport (GO:2000641) | 3.46586992 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.46133757 |
| 33 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.45131151 |
| 34 | tolerance induction (GO:0002507) | 3.40401218 |
| 35 | negative thymic T cell selection (GO:0045060) | 3.40391958 |
| 36 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.38570162 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37958006 |
| 38 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.35245179 |
| 39 | negative regulation of interleukin-1 production (GO:0032692) | 3.35233449 |
| 40 | peptidyl-lysine dimethylation (GO:0018027) | 3.33607797 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.32485271 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.32134236 |
| 43 | cellular response to unfolded protein (GO:0034620) | 3.31983777 |
| 44 | regulation of antigen processing and presentation (GO:0002577) | 3.30023926 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.29381325 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.28399192 |
| 47 | regulation of translational termination (GO:0006449) | 3.27901693 |
| 48 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27335533 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.24650002 |
| 50 | T cell selection (GO:0045058) | 3.22293950 |
| 51 | negative T cell selection (GO:0043383) | 3.21382803 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.20083782 |
| 53 | ER-nucleus signaling pathway (GO:0006984) | 3.18072207 |
| 54 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.16092610 |
| 55 | heterochromatin organization (GO:0070828) | 3.15616632 |
| 56 | leukocyte aggregation (GO:0070486) | 3.14772913 |
| 57 | cellular response to topologically incorrect protein (GO:0035967) | 3.12110138 |
| 58 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.11547056 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08994644 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.08200425 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.07394374 |
| 62 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.05741973 |
| 63 | NADPH regeneration (GO:0006740) | 3.05549765 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03954336 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99268875 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98709564 |
| 67 | detection of external biotic stimulus (GO:0098581) | 2.97738969 |
| 68 | regulation of chromatin binding (GO:0035561) | 2.96205256 |
| 69 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96124638 |
| 70 | negative regulation of RNA splicing (GO:0033119) | 2.95498898 |
| 71 | apoptotic cell clearance (GO:0043277) | 2.92897949 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92699672 |
| 73 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89883180 |
| 74 | negative regulation of cell killing (GO:0031342) | 2.89883180 |
| 75 | apoptotic process involved in morphogenesis (GO:0060561) | 2.89579821 |
| 76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88444614 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87237598 |
| 78 | cellular extravasation (GO:0045123) | 2.85150626 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.84652824 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 2.84434363 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83507458 |
| 82 | positive regulation of protein deacetylation (GO:0090312) | 2.81710315 |
| 83 | positive regulation of histone acetylation (GO:0035066) | 2.81691104 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 2.81637511 |
| 85 | germinal center formation (GO:0002467) | 2.80857355 |
| 86 | sodium ion export (GO:0071436) | 2.79036081 |
| 87 | vesicle coating (GO:0006901) | 2.77459493 |
| 88 | DNA unwinding involved in DNA replication (GO:0006268) | 2.77273869 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.76840233 |
| 90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76438479 |
| 91 | positive regulation of lamellipodium assembly (GO:0010592) | 2.75836636 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.75506131 |
| 93 | RNA stabilization (GO:0043489) | 2.75436098 |
| 94 | mRNA stabilization (GO:0048255) | 2.75436098 |
| 95 | positive T cell selection (GO:0043368) | 2.75218884 |
| 96 | activated T cell proliferation (GO:0050798) | 2.74440595 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.74412856 |
| 98 | mannose metabolic process (GO:0006013) | 2.73448761 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.73293862 |
| 100 | regulation of ARF GTPase activity (GO:0032312) | 2.72863141 |
| 101 | cortical actin cytoskeleton organization (GO:0030866) | 2.72541900 |
| 102 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.72022773 |
| 103 | regulation of mast cell activation (GO:0033003) | 2.71970742 |
| 104 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.71728417 |
| 105 | regulation of protein heterodimerization activity (GO:0043497) | 2.70746602 |
| 106 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.69640420 |
| 107 | negative regulation of fatty acid transport (GO:2000192) | 2.68296844 |
| 108 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.67977248 |
| 109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67424288 |
| 110 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67417580 |
| 111 | dosage compensation (GO:0007549) | 2.66509337 |
| 112 | detection of biotic stimulus (GO:0009595) | 2.66381186 |
| 113 | corticosteroid receptor signaling pathway (GO:0031958) | 2.66051330 |
| 114 | positive regulation of protein acetylation (GO:1901985) | 2.66003854 |
| 115 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 2.66003854 |
| 116 | positive regulation of mast cell degranulation (GO:0043306) | 2.65316581 |
| 117 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65316581 |
| 118 | response to endoplasmic reticulum stress (GO:0034976) | 2.65150420 |
| 119 | modulation by virus of host process (GO:0019054) | 2.63682200 |
| 120 | axon extension involved in axon guidance (GO:0048846) | 2.63666650 |
| 121 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.63666650 |
| 122 | regulation of regulated secretory pathway (GO:1903305) | 2.63547587 |
| 123 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.63212263 |
| 124 | cellular response to exogenous dsRNA (GO:0071360) | 2.62769219 |
| 125 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62470259 |
| 126 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.62343636 |
| 127 | neutrophil activation (GO:0042119) | 2.61829492 |
| 128 | amyloid precursor protein catabolic process (GO:0042987) | 2.61694801 |
| 129 | barbed-end actin filament capping (GO:0051016) | 2.60872148 |
| 130 | protein localization to endosome (GO:0036010) | 2.60708731 |
| 131 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60419670 |
| 132 | response to host immune response (GO:0052572) | 2.60419670 |
| 133 | regulation of histone phosphorylation (GO:0033127) | 2.59217920 |
| 134 | stress fiber assembly (GO:0043149) | 2.58116167 |
| 135 | response to type I interferon (GO:0034340) | 2.57389330 |
| 136 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.56938438 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.56857750 |
| 138 | receptor catabolic process (GO:0032801) | 2.56746051 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56545060 |
| 140 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.56525422 |
| 141 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.55897325 |
| 142 | negative regulation of mRNA metabolic process (GO:1903312) | 2.55551674 |
| 143 | positive regulation of RNA splicing (GO:0033120) | 2.55057212 |
| 144 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.54447758 |
| 145 | positive regulation of defense response to virus by host (GO:0002230) | 2.53413843 |
| 146 | thymic T cell selection (GO:0045061) | 2.53069370 |
| 147 | negative regulation of mRNA processing (GO:0050686) | 2.52940823 |
| 148 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.52563459 |
| 149 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52161980 |
| 150 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52025481 |
| 151 | response to host (GO:0075136) | 2.52025481 |
| 152 | response to host defenses (GO:0052200) | 2.52025481 |
| 153 | N-acetylneuraminate metabolic process (GO:0006054) | 2.50620741 |
| 154 | positive regulation of Rap GTPase activity (GO:0032854) | 2.50596245 |
| 155 | natural killer cell differentiation (GO:0001779) | 2.50475130 |
| 156 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49931048 |
| 157 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49818951 |
| 158 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.49549901 |
| 159 | positive regulation of B cell differentiation (GO:0045579) | 2.47772837 |
| 160 | microglial cell activation (GO:0001774) | 2.47564291 |
| 161 | positive regulation of lamellipodium organization (GO:1902745) | 2.47522657 |
| 162 | detection of molecule of bacterial origin (GO:0032490) | 2.46507142 |
| 163 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.46414810 |
| 164 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.46280241 |
| 165 | signal complex assembly (GO:0007172) | 2.45273129 |
| 166 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45237922 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.45140800 |
| 168 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.44512461 |
| 169 | response to protozoan (GO:0001562) | 2.44420692 |
| 170 | pre-miRNA processing (GO:0031054) | 2.43966546 |
| 171 | type I interferon signaling pathway (GO:0060337) | 2.43691403 |
| 172 | cellular response to type I interferon (GO:0071357) | 2.43691403 |
| 173 | embryonic foregut morphogenesis (GO:0048617) | 2.42599235 |
| 174 | NLS-bearing protein import into nucleus (GO:0006607) | 2.42485964 |
| 175 | granulocyte activation (GO:0036230) | 2.41825966 |
| 176 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.41483428 |
| 177 | T cell apoptotic process (GO:0070231) | 2.41396651 |
| 178 | cerebellar Purkinje cell layer development (GO:0021680) | 2.41180202 |
| 179 | activation of JUN kinase activity (GO:0007257) | 2.40913859 |
| 180 | protein-DNA complex disassembly (GO:0032986) | 2.40606560 |
| 181 | nucleosome disassembly (GO:0006337) | 2.40606560 |
| 182 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.40435524 |
| 183 | negative regulation of microtubule polymerization (GO:0031115) | 2.38648407 |
| 184 | apoptotic process involved in development (GO:1902742) | 2.37529988 |
| 185 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.36049327 |
| 186 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.35983487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 4.00717404 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83433351 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.18289810 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13178127 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.08414310 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.57371942 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.52221830 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.50550215 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.47376637 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46369780 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.40908989 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40586415 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.31388893 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20024999 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.18600423 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07863170 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06118407 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.03095537 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01061068 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.98089464 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84328213 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82486386 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.81507523 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81267494 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80933925 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80765214 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80713953 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79178327 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77097837 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72962147 |
| 31 | GATA1_19941826_ChIP-Seq_K562_Human | 1.69050686 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66787997 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65756429 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63301983 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61494519 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60805623 |
| 37 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54669451 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52824190 |
| 39 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.52509861 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52097658 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51902331 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50636451 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.50176578 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49925227 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49849889 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.49428526 |
| 47 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.46339349 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45859436 |
| 49 | ATF3_27146783_Chip-Seq_COLON_Human | 1.44512376 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43227262 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42678096 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41603662 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41398686 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39990972 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38975911 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38852678 |
| 57 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.38681022 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37430195 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37119186 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36957141 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36912473 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34609202 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34331737 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34319223 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34092548 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33060718 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31373852 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31023375 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30879642 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29796304 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29105523 |
| 72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29062990 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.29026912 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28862949 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28793122 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26645392 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26205610 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25909838 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25294656 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24728939 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24309623 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23451467 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23311072 |
| 84 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22350315 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21654906 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21463001 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21277820 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20441084 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20329911 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20148428 |
| 91 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19677463 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18869703 |
| 93 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18219524 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17843029 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17271991 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17027503 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17001620 |
| 98 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15825499 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15575099 |
| 100 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13089842 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12878796 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12259201 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12141473 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11975153 |
| 105 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11025895 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10638602 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10420446 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10388847 |
| 109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10098219 |
| 110 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09787134 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09665275 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08776682 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08157438 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08019055 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07776268 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07187473 |
| 117 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07166237 |
| 118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07092471 |
| 119 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06775365 |
| 120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06241477 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06204475 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05971894 |
| 123 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05722989 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 1.05583500 |
| 125 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05378993 |
| 126 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04741511 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03526435 |
| 128 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02837226 |
| 129 | MYB_26560356_Chip-Seq_TH2_Human | 1.02231255 |
| 130 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00568243 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99409203 |
| 132 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99084367 |
| 133 | MYB_26560356_Chip-Seq_TH1_Human | 0.98776396 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98347432 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95816088 |
| 136 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95608162 |
| 137 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94999643 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94724064 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94213603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 4.60167256 |
| 2 | MP0003303_peritoneal_inflammation | 3.54821731 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.35593444 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.10402996 |
| 5 | MP0005076_abnormal_cell_differentiation | 3.02814560 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.97165770 |
| 7 | MP0008961_abnormal_basal_metabolism | 2.70651589 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.67510389 |
| 9 | MP0003724_increased_susceptibility_to | 2.59883190 |
| 10 | MP0009278_abnormal_bone_marrow | 2.58365562 |
| 11 | MP0002419_abnormal_innate_immunity | 2.53986562 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.43836141 |
| 13 | MP0005025_abnormal_response_to | 2.43347648 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.32822009 |
| 15 | MP0005671_abnormal_response_to | 2.19562245 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.12654917 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.10776911 |
| 18 | MP0006054_spinal_hemorrhage | 2.07115337 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.93126096 |
| 20 | MP0009785_altered_susceptibility_to | 1.91832850 |
| 21 | MP0004858_abnormal_nervous_system | 1.89221587 |
| 22 | MP0001849_ear_inflammation | 1.81464542 |
| 23 | MP0005451_abnormal_body_composition | 1.73211185 |
| 24 | MP0006082_CNS_inflammation | 1.66278364 |
| 25 | MP0002234_abnormal_pharynx_morphology | 1.63848567 |
| 26 | MP0000685_abnormal_immune_system | 1.63842015 |
| 27 | MP0002933_joint_inflammation | 1.57981862 |
| 28 | MP0001663_abnormal_digestive_system | 1.54418536 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.51824714 |
| 30 | MP0009840_abnormal_foam_cell | 1.51079691 |
| 31 | MP0004947_skin_inflammation | 1.51076981 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.51016859 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.49898248 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.47145912 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.43186438 |
| 36 | MP0010307_abnormal_tumor_latency | 1.38238077 |
| 37 | MP0004510_myositis | 1.33838407 |
| 38 | MP0003436_decreased_susceptibility_to | 1.31442934 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.31037482 |
| 40 | MP0005083_abnormal_biliary_tract | 1.30953452 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.30583913 |
| 42 | MP0005023_abnormal_wound_healing | 1.29326363 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.27743308 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.27227860 |
| 45 | MP0008469_abnormal_protein_level | 1.25030481 |
| 46 | MP0004381_abnormal_hair_follicle | 1.24988340 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.22269938 |
| 48 | MP0001730_embryonic_growth_arrest | 1.21049461 |
| 49 | MP0005390_skeleton_phenotype | 1.19781952 |
| 50 | MP0003091_abnormal_cell_migration | 1.19511040 |
| 51 | MP0000733_abnormal_muscle_development | 1.18648171 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.18164435 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.18164435 |
| 54 | MP0003329_amyloid_beta_deposits | 1.15781582 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.14931607 |
| 56 | MP0004130_abnormal_muscle_cell | 1.14586547 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.14306250 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.13540500 |
| 59 | MP0009764_decreased_sensitivity_to | 1.13407073 |
| 60 | MP0005381_digestive/alimentary_phenotyp | 1.11036143 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.10288977 |
| 62 | MP0002398_abnormal_bone_marrow | 1.10147612 |
| 63 | MP0009053_abnormal_anal_canal | 1.09328044 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.09061499 |
| 65 | MP0004197_abnormal_fetal_growth/weight/ | 1.08509668 |
| 66 | MP0003279_aneurysm | 1.08263033 |
| 67 | MP0001873_stomach_inflammation | 1.06753266 |
| 68 | MP0001790_abnormal_immune_system | 1.04976363 |
| 69 | MP0005387_immune_system_phenotype | 1.04976363 |
| 70 | MP0004859_abnormal_synaptic_plasticity | 1.04361987 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.03171543 |
| 72 | MP0000604_amyloidosis | 1.02431805 |
| 73 | MP0003115_abnormal_respiratory_system | 1.00470424 |
| 74 | MP0000428_abnormal_craniofacial_morphol | 0.98730873 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.98537189 |
| 76 | MP0001800_abnormal_humoral_immune | 0.98511637 |
| 77 | MP0003866_abnormal_defecation | 0.98045316 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 0.97779355 |
| 79 | MP0002132_abnormal_respiratory_system | 0.97516552 |
| 80 | MP0003828_pulmonary_edema | 0.97107435 |
| 81 | MP0000858_altered_metastatic_potential | 0.96971994 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.96873226 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.95588088 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.93914395 |
| 85 | MP0000249_abnormal_blood_vessel | 0.93258155 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.93231982 |
| 87 | MP0002080_prenatal_lethality | 0.93162026 |
| 88 | MP0001851_eye_inflammation | 0.92893161 |
| 89 | MP0000490_abnormal_crypts_of | 0.92891772 |
| 90 | MP0002084_abnormal_developmental_patter | 0.92492819 |
| 91 | MP0001958_emphysema | 0.92004378 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.91658564 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.91524054 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.90240244 |
| 95 | MP0002722_abnormal_immune_system | 0.90206709 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.87891422 |
| 97 | MP0009672_abnormal_birth_weight | 0.87836717 |
| 98 | MP0000462_abnormal_digestive_system | 0.87447650 |
| 99 | MP0001819_abnormal_immune_cell | 0.87110916 |
| 100 | MP0003075_altered_response_to | 0.85965315 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.85892382 |
| 102 | MP0000716_abnormal_immune_system | 0.85504607 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.84613184 |
| 104 | MP0003119_abnormal_digestive_system | 0.84586877 |
| 105 | MP0002085_abnormal_embryonic_tissue | 0.83343542 |
| 106 | MP0010155_abnormal_intestine_physiology | 0.83240273 |
| 107 | MP0002429_abnormal_blood_cell | 0.82766284 |
| 108 | MP0004233_abnormal_muscle_weight | 0.82744762 |
| 109 | MP0000569_abnormal_digit_pigmentation | 0.82302791 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.81967077 |
| 111 | MP0003045_fibrosis | 0.81773128 |
| 112 | MP0005621_abnormal_cell_physiology | 0.81680584 |
| 113 | MP0004883_abnormal_blood_vessel | 0.81346932 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.81286922 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.81253108 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.79976884 |
| 117 | MP0003123_paternal_imprinting | 0.79799521 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.79649389 |
| 119 | MP0002405_respiratory_system_inflammati | 0.78871988 |
| 120 | MP0002086_abnormal_extraembryonic_tissu | 0.78861710 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.78643754 |
| 122 | MP0005164_abnormal_response_to | 0.78053403 |
| 123 | MP0005310_abnormal_salivary_gland | 0.77914639 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.77900609 |
| 125 | MP0008770_decreased_survivor_rate | 0.77305210 |
| 126 | MP0002723_abnormal_immune_serum | 0.76936670 |
| 127 | MP0000470_abnormal_stomach_morphology | 0.76643549 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.75893689 |
| 129 | MP0001697_abnormal_embryo_size | 0.75552991 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.75441775 |
| 131 | MP0005000_abnormal_immune_tolerance | 0.75426569 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.74143824 |
| 133 | MP0008260_abnormal_autophagy | 0.73950610 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.73777186 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.73630952 |
| 136 | MP0000371_diluted_coat_color | 0.72803767 |
| 137 | MP0009931_abnormal_skin_appearance | 0.69243650 |
| 138 | MP0002277_abnormal_respiratory_mucosa | 0.68027842 |
| 139 | MP0004043_abnormal_pH_regulation | 0.67961391 |
| 140 | MP0001664_abnormal_digestion | 0.67429250 |
| 141 | MP0003795_abnormal_bone_structure | 0.66803671 |
| 142 | MP0000678_abnormal_parathyroid_gland | 0.66018254 |
| 143 | MP0000343_altered_response_to | 0.65520210 |
| 144 | MP0008874_decreased_physiological_sensi | 0.64572144 |
| 145 | MP0002136_abnormal_kidney_physiology | 0.61939312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 3.67591213 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.65547606 |
| 3 | Global brain atrophy (HP:0002283) | 3.48862209 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43228009 |
| 5 | Hyperacusis (HP:0010780) | 3.39560980 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.32653210 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.31402505 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28727156 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.25517885 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.21717955 |
| 11 | Orchitis (HP:0100796) | 3.14529733 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.12071358 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.10166115 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05905051 |
| 15 | Hand muscle atrophy (HP:0009130) | 3.04440306 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.01115414 |
| 17 | Breast hypoplasia (HP:0003187) | 2.88473804 |
| 18 | Protrusio acetabuli (HP:0003179) | 2.84729030 |
| 19 | Upper limb amyotrophy (HP:0009129) | 2.84294864 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 2.84294864 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.76241636 |
| 22 | Optic neuritis (HP:0100653) | 2.76241636 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75663879 |
| 24 | Mucopolysacchariduria (HP:0008155) | 2.75663879 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69976943 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69976943 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67899166 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67899166 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67899166 |
| 30 | Meningitis (HP:0001287) | 2.61017216 |
| 31 | Gastrointestinal stroma tumor (HP:0100723) | 2.59952377 |
| 32 | Shallow orbits (HP:0000586) | 2.59046300 |
| 33 | Birth length less than 3rd percentile (HP:0003561) | 2.55815459 |
| 34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.54614175 |
| 35 | Pustule (HP:0200039) | 2.53617180 |
| 36 | Encephalitis (HP:0002383) | 2.53048374 |
| 37 | Insomnia (HP:0100785) | 2.51811229 |
| 38 | Obstructive lung disease (HP:0006536) | 2.50642436 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50642436 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.45459907 |
| 41 | Genu recurvatum (HP:0002816) | 2.43949526 |
| 42 | Broad face (HP:0000283) | 2.42645032 |
| 43 | Recurrent skin infections (HP:0001581) | 2.38822842 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.31877307 |
| 45 | Vasculitis (HP:0002633) | 2.25916835 |
| 46 | Ankyloglossia (HP:0010296) | 2.24875821 |
| 47 | Renal duplication (HP:0000075) | 2.24337692 |
| 48 | Ankle contracture (HP:0006466) | 2.23174019 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.21935297 |
| 50 | Diplopia (HP:0000651) | 2.21935297 |
| 51 | Neoplasm of the heart (HP:0100544) | 2.21832355 |
| 52 | Apathy (HP:0000741) | 2.20470941 |
| 53 | Increased density of long bones (HP:0006392) | 2.20240662 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.19531079 |
| 55 | Stomatitis (HP:0010280) | 2.19022550 |
| 56 | Macroorchidism (HP:0000053) | 2.19002087 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.18623077 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.16718937 |
| 59 | Bladder diverticulum (HP:0000015) | 2.16334329 |
| 60 | Bowel diverticulosis (HP:0005222) | 2.16151784 |
| 61 | Hypochromic anemia (HP:0001931) | 2.15230436 |
| 62 | Dilatation of the ascending aorta (HP:0005111) | 2.15185042 |
| 63 | Enlarged penis (HP:0000040) | 2.14545449 |
| 64 | Diminished motivation (HP:0000745) | 2.14434075 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14135039 |
| 66 | Cellulitis (HP:0100658) | 2.13741202 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.12380402 |
| 68 | Elfin facies (HP:0004428) | 2.12260501 |
| 69 | Abnormality of the thoracic spine (HP:0100711) | 2.12019867 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.10585216 |
| 71 | Ulnar bowing (HP:0003031) | 2.08941765 |
| 72 | Hemoptysis (HP:0002105) | 2.08478587 |
| 73 | Urticaria (HP:0001025) | 2.07737646 |
| 74 | Abnormality of oral frenula (HP:0000190) | 2.07072576 |
| 75 | Pointed chin (HP:0000307) | 2.06874446 |
| 76 | Severe short stature (HP:0003510) | 2.05884039 |
| 77 | Increased serum ferritin (HP:0003281) | 2.05771945 |
| 78 | Cervical subluxation (HP:0003308) | 2.05733850 |
| 79 | Mesangial abnormality (HP:0001966) | 2.04620572 |
| 80 | Recurrent viral infections (HP:0004429) | 2.04309150 |
| 81 | Ovoid vertebral bodies (HP:0003300) | 2.02332703 |
| 82 | Ependymoma (HP:0002888) | 2.01636905 |
| 83 | Hypercortisolism (HP:0001578) | 2.00791458 |
| 84 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.00209162 |
| 85 | Short 4th metacarpal (HP:0010044) | 2.00209162 |
| 86 | Premature rupture of membranes (HP:0001788) | 1.99953494 |
| 87 | Achilles tendon contracture (HP:0001771) | 1.99418393 |
| 88 | Long toe (HP:0010511) | 1.99400240 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.96991358 |
| 90 | Aneurysm (HP:0002617) | 1.96581082 |
| 91 | Amyloidosis (HP:0011034) | 1.96432687 |
| 92 | Clumsiness (HP:0002312) | 1.96269654 |
| 93 | Flat acetabular roof (HP:0003180) | 1.95395526 |
| 94 | Lymphangioma (HP:0100764) | 1.94724304 |
| 95 | Polycythemia (HP:0001901) | 1.93626751 |
| 96 | Mitral valve prolapse (HP:0001634) | 1.93016299 |
| 97 | Hallux valgus (HP:0001822) | 1.91277903 |
| 98 | Recurrent bronchitis (HP:0002837) | 1.90863082 |
| 99 | Gingivitis (HP:0000230) | 1.89151166 |
| 100 | Deviation of the hallux (HP:0010051) | 1.89016772 |
| 101 | Abnormality of the lower motor neuron (HP:0002366) | 1.88783066 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 1.88663536 |
| 103 | Broad palm (HP:0001169) | 1.88619813 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 1.88080209 |
| 105 | Cheilitis (HP:0100825) | 1.87917500 |
| 106 | Aortic aneurysm (HP:0004942) | 1.87734778 |
| 107 | Abnormality of the fingertips (HP:0001211) | 1.87568817 |
| 108 | Peritonitis (HP:0002586) | 1.87388923 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 1.87148782 |
| 110 | Eczematoid dermatitis (HP:0000976) | 1.86977043 |
| 111 | Interstitial pulmonary disease (HP:0006530) | 1.86808174 |
| 112 | Deep palmar crease (HP:0006191) | 1.84605131 |
| 113 | Verrucae (HP:0200043) | 1.82628611 |
| 114 | Papilloma (HP:0012740) | 1.82628611 |
| 115 | Coxa vara (HP:0002812) | 1.82594612 |
| 116 | Joint stiffness (HP:0001387) | 1.82499043 |
| 117 | Overriding aorta (HP:0002623) | 1.81618134 |
| 118 | Posterior subcapsular cataract (HP:0007787) | 1.81349001 |
| 119 | Keratoconjunctivitis (HP:0001096) | 1.81291575 |
| 120 | Disproportionate tall stature (HP:0001519) | 1.81137143 |
| 121 | Nasal polyposis (HP:0100582) | 1.80985604 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80945246 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80945246 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80945246 |
| 125 | Abnormality of the nasal mucosa (HP:0000433) | 1.80785940 |
| 126 | J-shaped sella turcica (HP:0002680) | 1.79930802 |
| 127 | Chronic otitis media (HP:0000389) | 1.79907911 |
| 128 | Flat cornea (HP:0007720) | 1.79600401 |
| 129 | Striae distensae (HP:0001065) | 1.78977447 |
| 130 | Broad metatarsal (HP:0001783) | 1.78809152 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.77840691 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.77610898 |
| 133 | Hypertensive crisis (HP:0100735) | 1.77481449 |
| 134 | Restrictive lung disease (HP:0002091) | 1.77078181 |
| 135 | Supranuclear gaze palsy (HP:0000605) | 1.76646804 |
| 136 | Neurodegeneration (HP:0002180) | 1.76345786 |
| 137 | Loss of speech (HP:0002371) | 1.76161476 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.75639839 |
| 139 | Renovascular hypertension (HP:0100817) | 1.75367979 |
| 140 | Turricephaly (HP:0000262) | 1.74713446 |
| 141 | Polygenic inheritance (HP:0010982) | 1.74593142 |
| 142 | Large for gestational age (HP:0001520) | 1.74457626 |
| 143 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74012324 |
| 144 | Increased IgE level (HP:0003212) | 1.72373245 |
| 145 | Microretrognathia (HP:0000308) | 1.71988576 |
| 146 | Cardiomegaly (HP:0001640) | 1.71741753 |
| 147 | Fatigue (HP:0012378) | 1.71690039 |
| 148 | Spondylolisthesis (HP:0003302) | 1.69226433 |
| 149 | Onion bulb formation (HP:0003383) | 1.68925742 |
| 150 | Metaphyseal cupping (HP:0003021) | 1.68466927 |
| 151 | Astrocytoma (HP:0009592) | 1.68235961 |
| 152 | Abnormality of the astrocytes (HP:0100707) | 1.68235961 |
| 153 | Annular pancreas (HP:0001734) | 1.67978437 |
| 154 | Thin bony cortex (HP:0002753) | 1.66860199 |
| 155 | Colitis (HP:0002583) | 1.65403775 |
| 156 | Emphysema (HP:0002097) | 1.65402898 |
| 157 | Thoracolumbar scoliosis (HP:0002944) | 1.65109444 |
| 158 | Deformed sella turcica (HP:0002681) | 1.64797286 |
| 159 | Thoracic kyphosis (HP:0002942) | 1.64743288 |
| 160 | Spinal muscular atrophy (HP:0007269) | 1.60455468 |
| 161 | Lumbar hyperlordosis (HP:0002938) | 1.60389512 |
| 162 | Short phalanx of the thumb (HP:0009660) | 1.59761878 |
| 163 | Long palpebral fissure (HP:0000637) | 1.58247428 |
| 164 | Cerebral inclusion bodies (HP:0100314) | 1.58157481 |
| 165 | Adenoma sebaceum (HP:0009720) | 1.57907410 |
| 166 | Angiofibromas (HP:0010615) | 1.57907410 |
| 167 | Abnormality of the motor neurons (HP:0002450) | 1.56894654 |
| 168 | Abnormal neuron morphology (HP:0012757) | 1.56894654 |
| 169 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.56881627 |
| 170 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.56792215 |
| 171 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.55940006 |
| 172 | Inflammation of the large intestine (HP:0002037) | 1.55483747 |
| 173 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.54916761 |
| 174 | Papilledema (HP:0001085) | 1.54811965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.92333924 |
| 2 | ERN1 | 4.40221444 |
| 3 | MAP3K10 | 3.65271916 |
| 4 | EEF2K | 3.49697700 |
| 5 | PKN2 | 3.28000615 |
| 6 | RIPK4 | 3.22474679 |
| 7 | PRPF4B | 2.40837015 |
| 8 | IRAK4 | 2.37133868 |
| 9 | TAOK3 | 2.34100579 |
| 10 | MAP4K1 | 2.10485305 |
| 11 | PTK6 | 1.97549915 |
| 12 | ICK | 1.83265373 |
| 13 | SCYL2 | 1.83234937 |
| 14 | SIK1 | 1.82658561 |
| 15 | RIPK1 | 1.76735723 |
| 16 | CDK12 | 1.74631627 |
| 17 | TAOK1 | 1.62595026 |
| 18 | PDGFRA | 1.58624441 |
| 19 | LRRK2 | 1.57979477 |
| 20 | GRK6 | 1.54194210 |
| 21 | TNK2 | 1.51187897 |
| 22 | MAP3K13 | 1.50930145 |
| 23 | SMG1 | 1.50465295 |
| 24 | KSR2 | 1.49442644 |
| 25 | PAK4 | 1.49258135 |
| 26 | TESK2 | 1.47414623 |
| 27 | ALK | 1.35495165 |
| 28 | SIK2 | 1.31663888 |
| 29 | MAPK15 | 1.31221376 |
| 30 | MAP3K9 | 1.29306265 |
| 31 | PASK | 1.23541958 |
| 32 | IRAK3 | 1.23462121 |
| 33 | MAP3K14 | 1.21987739 |
| 34 | STK10 | 1.21855670 |
| 35 | FGFR4 | 1.20846705 |
| 36 | BMX | 1.20582896 |
| 37 | EPHB1 | 1.20471300 |
| 38 | DDR2 | 1.18489913 |
| 39 | TYRO3 | 1.17817539 |
| 40 | EPHB2 | 1.15939417 |
| 41 | KSR1 | 1.12905396 |
| 42 | DAPK2 | 1.12020485 |
| 43 | MTOR | 1.07085877 |
| 44 | INSRR | 1.04850526 |
| 45 | RPS6KA6 | 1.02441186 |
| 46 | TBK1 | 1.00889136 |
| 47 | TESK1 | 0.99376576 |
| 48 | NEK2 | 0.99100850 |
| 49 | TTN | 0.97318767 |
| 50 | PRKD3 | 0.96647012 |
| 51 | NTRK1 | 0.96056173 |
| 52 | PTK2 | 0.96012445 |
| 53 | PDPK1 | 0.93762202 |
| 54 | HIPK2 | 0.92976593 |
| 55 | CAMKK2 | 0.92675787 |
| 56 | MAP3K3 | 0.91563455 |
| 57 | ZAP70 | 0.91514336 |
| 58 | SIK3 | 0.87899558 |
| 59 | TYK2 | 0.87286440 |
| 60 | CSF1R | 0.86600388 |
| 61 | CAMKK1 | 0.85841784 |
| 62 | IKBKB | 0.85655803 |
| 63 | RET | 0.85653077 |
| 64 | CAMK1D | 0.85405041 |
| 65 | MAP3K8 | 0.83804474 |
| 66 | PTK2B | 0.83367128 |
| 67 | MAPK12 | 0.82353923 |
| 68 | DYRK1B | 0.82227929 |
| 69 | MAP3K6 | 0.79579666 |
| 70 | IKBKE | 0.79239306 |
| 71 | MAP2K6 | 0.79079757 |
| 72 | LCK | 0.78381249 |
| 73 | WNK4 | 0.78272945 |
| 74 | PAK2 | 0.77037334 |
| 75 | PDK1 | 0.76732281 |
| 76 | LYN | 0.74810691 |
| 77 | TGFBR2 | 0.74407474 |
| 78 | EPHA2 | 0.74379253 |
| 79 | FGR | 0.73377818 |
| 80 | BTK | 0.73129358 |
| 81 | RPS6KL1 | 0.70571726 |
| 82 | RPS6KC1 | 0.70571726 |
| 83 | MATK | 0.69599981 |
| 84 | PAK6 | 0.68284842 |
| 85 | FES | 0.67873522 |
| 86 | PRKCH | 0.67805435 |
| 87 | MAP3K11 | 0.67191701 |
| 88 | MAP2K1 | 0.67011059 |
| 89 | HCK | 0.66645696 |
| 90 | IRAK1 | 0.65514354 |
| 91 | ADRBK2 | 0.65503330 |
| 92 | CSK | 0.65279401 |
| 93 | JAK3 | 0.63933438 |
| 94 | MAPK7 | 0.63414736 |
| 95 | BLK | 0.62315990 |
| 96 | ACVR1B | 0.61203497 |
| 97 | PRKG2 | 0.59238159 |
| 98 | NEK9 | 0.58270709 |
| 99 | UHMK1 | 0.56337923 |
| 100 | ILK | 0.56059671 |
| 101 | JAK1 | 0.55291344 |
| 102 | FLT3 | 0.54228932 |
| 103 | PDGFRB | 0.54169278 |
| 104 | JAK2 | 0.53980156 |
| 105 | MAP2K2 | 0.53588682 |
| 106 | MARK3 | 0.53439961 |
| 107 | CDK4 | 0.52944722 |
| 108 | MAP3K1 | 0.52552909 |
| 109 | RPS6KA4 | 0.52471873 |
| 110 | MAPKAPK2 | 0.52318436 |
| 111 | RPS6KA2 | 0.52204132 |
| 112 | MARK2 | 0.51861036 |
| 113 | EPHA3 | 0.51734603 |
| 114 | MAP3K7 | 0.51318531 |
| 115 | LATS2 | 0.51273203 |
| 116 | MAPKAPK3 | 0.50757377 |
| 117 | NEK1 | 0.50410654 |
| 118 | CAMK1G | 0.49334402 |
| 119 | PRKD2 | 0.48913877 |
| 120 | SYK | 0.48665736 |
| 121 | ITK | 0.47577470 |
| 122 | MAP2K3 | 0.47141973 |
| 123 | TRPM7 | 0.45008615 |
| 124 | FGFR1 | 0.43905296 |
| 125 | PRKCQ | 0.42157859 |
| 126 | CLK1 | 0.42051873 |
| 127 | DMPK | 0.41052440 |
| 128 | MAP3K2 | 0.40614644 |
| 129 | TSSK6 | 0.40460983 |
| 130 | RPS6KA1 | 0.39643460 |
| 131 | CDK6 | 0.39082349 |
| 132 | CDC42BPA | 0.37375639 |
| 133 | BRD4 | 0.36964349 |
| 134 | KIT | 0.36455297 |
| 135 | SRC | 0.35145186 |
| 136 | TGFBR1 | 0.34825201 |
| 137 | MINK1 | 0.34595067 |
| 138 | DAPK1 | 0.33621755 |
| 139 | PRKD1 | 0.33230220 |
| 140 | MAPK11 | 0.33046425 |
| 141 | NTRK2 | 0.32898403 |
| 142 | CHUK | 0.32304264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.27408771 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14268592 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94978987 |
| 4 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.90014182 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86751722 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81547369 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.78641090 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.77151417 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.75955899 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70573857 |
| 11 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.69755551 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69196636 |
| 13 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.68701126 |
| 14 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.68092210 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63469373 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62415069 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61484671 |
| 18 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.61338233 |
| 19 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57667336 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53901130 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50020105 |
| 22 | Glioma_Homo sapiens_hsa05214 | 1.47971481 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.47186334 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.46967932 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44433635 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.44223843 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42295876 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38581851 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.38075456 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.37605936 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34630179 |
| 32 | Colorectal cancer_Homo sapiens_hsa05210 | 1.33228135 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31714354 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31611629 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29450334 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.27284266 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27186563 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26840176 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24087999 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19901579 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19818802 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.14426080 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12355131 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09048533 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.08438273 |
| 46 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06297442 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05772664 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.05184725 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04184433 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04058539 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03424536 |
| 52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01926552 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01353829 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00755930 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.98867470 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98675600 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97192595 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97142488 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.97113837 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96810003 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95460838 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94956013 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.94096893 |
| 64 | * Hepatitis B_Homo sapiens_hsa05161 | 0.93837167 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.93451878 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.92303202 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91425964 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.91364385 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90563347 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90361230 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89939014 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.89426688 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.86231999 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85657058 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85176614 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84891101 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84794656 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.84626603 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.84364132 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83453905 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82695122 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82387653 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81772122 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81286568 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.80060163 |
| 86 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79569324 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78540602 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78201546 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77954559 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.77895454 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75880510 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75377962 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73345361 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73008966 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72820810 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71988925 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69711640 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.69671252 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69517642 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69410815 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68556143 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68313642 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68249993 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.66079142 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65383777 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.64304623 |
| 107 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64303860 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64214066 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63971657 |
| 110 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.63338538 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.62824642 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61624678 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61493027 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60777753 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60704835 |
| 116 | Gap junction_Homo sapiens_hsa04540 | 0.60434886 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60233851 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.57989126 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57579856 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57209744 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57146761 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56226938 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55786880 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55458309 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55100282 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.54893064 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53296403 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53237340 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52347653 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51940872 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50477069 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49548317 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48274233 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46327224 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41065839 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39996930 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39688006 |
| 138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39481537 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36870330 |
| 140 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36087753 |

